Summary:
In adults with type 2 diabetes mellitus (T2DM), Bifidobacterium animalis subsp. lactis TISTR 2591 (BA-2591) probiotic supplementation significantly improved glycemic control and immune response compared to placebo, though it was associated with mild gastrointestinal side effects.
| PICO | Description |
|---|---|
| Population | Thai adults aged 35-65 years with type 2 diabetes mellitus receiving standard treatments. |
| Intervention | Bifidobacterium animalis subsp. lactis TISTR 2591 probiotic supplementation; dosing specifics as per study protocol. |
| Comparison | Placebo administered in a randomized, double-blind, placebo-controlled, crossover design. |
| Outcome | Significant improvements in glycemic control indicators and enhanced immune response; mild gastrointestinal side effects reported but no serious adverse events. |
Source: Wiritphon Khiaolaongam, et al. “Bifidobacterium animalis subsp. lactis TISTR 2591 Improves Glycemic Control and Immune Response in Adults with Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Placebo-Controlled Crossover Clinical Trial.” Read article here.
